MedPath

Evaluation safety and efficiency of early administration of Tranexamic acid in trauma patient

Phase 3
Conditions
Trauma.
Registration Number
IRCT20220507054758N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
66
Inclusion Criteria

All patients admitted with multiple trauma over than 15 years old with ABC trauma score more than 2 scores
patient satisfaction to study

Exclusion Criteria

pregnancy
brain injuries
coaglopathy
renal failure
using anticoaglants

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality. Timepoint: All days of hospital admission. Method of measurement: Discharge or death of patient.;Hemoglobin decrease. Timepoint: All days of hospital admission. Method of measurement: Hemoglobin in laboratory data.;Blood transfusion. Timepoint: All days of hospital admission. Method of measurement: Evaluate patient records.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath